Trial Profile
Phase I trial of ISIS HBVRx in volunteers
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 17 Jul 2023
Price :
$35
*
At a glance
- Drugs Bepirovirsen (Primary)
- Indications Hepatitis B
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Ionis Pharmaceuticals
- 31 Mar 2014 Planned number of patients changed to 30.
- 29 Nov 2013 New trial record